Vascular calcification (VC) is one of the major causes of cardiovascular morbidity and
mortality in patients with chronic kidney disease (CKD). VC is a complex process expressing …

First, we would like to briefly describe the changes in the arterial medial layer that occur in
association with atherosclerotic vascular damage, affecting the arterial stiffness5-8). The …

Background: Vascular calcification is a prevalent complication in chronic kidney disease and
contributes to increased cardiovascular morbidity and mortality. XBP1 (X-box binding protein …

Klotho is an identified longevity gene with beneficial pleiotropic effects on the kidney.
Evidence shows that a decline in serum Klotho level occurs in early chronic kidney disease …

Background: Arterial stiffness (AS), measured by arterial stiffness index (ASI), can be
considered as a major denominator in cardiovascular (CV) diseases. Thus, it remains …

This study aimed to explore whether brachial‐ankle pulse wave velocity (baPWV) and
brachial artery flow‐mediated dilation (FMD) or the interaction of both parameters are …

Background Arterial medial calcification (AMC) is associated with a high incidence of
cardiovascular risk in patients with type 2 diabetes and chronic kidney disease. Here, we …

Vascular calcification (VC) involves the deposition of calcium apatite in vascular intima or
media. Individuals of advanced age, having diabetes mellitus or chronic kidney disease …

Cardiovascular disease (CVD) is one of the greatest public health concerns and is the
leading cause of morbidity and mortality in the United States and worldwide. CVD is a broad …

Background Calciprotein particles (CPP) are colloidal aggregates of calcium phosphate and
the mineral-binding protein fetuin-A, and are potential mediators of cardiovascular disease …